Sanchez, Mark Arvie E.

HRN: 28-27-73  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2026
CEFTRIAXONE 1G (VIAL)
01/05/2026
01/12/2026
IV
2g
OD
Cap Mr
Waiting Final Action 
01/11/2026
AMOXICILLIN 500MG CAPSULE (CAP)
01/11/2026
01/24/2026
PO
2 Caps
BID
H. Pylori Infection
Checking Initial Appropriateness 
01/11/2026
CLARITHROMYCIN 500MG (CAP)
01/11/2026
01/24/2026
PO
500mg
BID
H.pylori Infection
Checking Initial Appropriateness 
01/15/2026
LEVOFLOXACIN 500MG (TAB)
01/15/2026
01/21/2026
PO
500 Mg
OD
Intraabdominal Infection
Waiting Final Action 
01/16/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/16/2026
01/23/2026
IV
4.5g
Q8hr
CAP-HR
Checking Initial Appropriateness 
01/16/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/16/2026
01/23/2026
IV
4.5g
Q6hr
CAP-HR
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: